Ibn Alhaytham Hospital (AMM:IBNH) Current Deferred Revenue: JOD0.00 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

AMM:IBNH Ibn Alhaytham Hospital AMM:IBNH
33 GF Score
Price JOD0.86
GF Value JOD0.84
Valuation Fairly Valued
! 9 Warning Signs
View Full Analysis

What is Ibn Alhaytham Hospital Current Deferred Revenue?

Ibn Alhaytham Hospital AMM:IBNH 33 Current Deferred Revenue is JOD0.00 Mil as of Mar. 2026. GuruFocus rates AMM:IBNH with a GF Score™ of 33/100 and a GF Value™ of JOD0.84 (Fairly Valued). The stock has 9 warning signs investors should review.

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Ibn Alhaytham Hospital's current deferred revenue for the quarter that ended in Mar. 2026 was JOD0.00 Mil.

Ibn Alhaytham Hospital Current Deferred Revenue Related Terms

Ibn Alhaytham Hospital Current Deferred Revenue Historical Data

* Premium members only.

The historical data trend for Ibn Alhaytham Hospital's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ibn Alhaytham Hospital Current Deferred Revenue Chart

Ibn Alhaytham Hospital Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Current Deferred Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Ibn Alhaytham Hospital Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Current Deferred Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
AMM:IBNH
33GF Score
Ibn Alhaytham Hospital AMM:IBNH
Current Deferred Revenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Current Deferred Revenue of JOD0.00 Mil mean?
Ibn Alhaytham Hospital (AMM:IBNH) has a Current Deferred Revenue of JOD0.00 Mil as of Mar. 2026. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on Ibn Alhaytham Hospital and its competitors.
Is Ibn Alhaytham Hospital's Current Deferred Revenue too high?
Ibn Alhaytham Hospital's current Current Deferred Revenue is JOD0.00 Mil. Overall, Ibn Alhaytham Hospital has a GF Score™ of 33/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Ibn Alhaytham Hospital's Current Deferred Revenue compare to HCA and THC?
Ibn Alhaytham Hospital's Current Deferred Revenue of JOD0.00 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Deferred Revenue for a Healthcare Providers & Services company?
A good Current Deferred Revenue depends on the Healthcare Providers & Services industry context. However, Current Deferred Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Deferred Revenue mean?
A high Current Deferred Revenue can signal that a stock is expensive relative to its fundamentals. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on Ibn Alhaytham Hospital and its competitors. Ibn Alhaytham Hospital's current Current Deferred Revenue is JOD0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ibn Alhaytham Hospital stock overvalued right now?
Based on GuruFocus' analysis, Ibn Alhaytham Hospital (AMM:IBNH) is currently considered Fairly Valued. The stock's GF Value™ is JOD0.84, compared to a current price of JOD0.86 — trading 2.4% above its estimated fair value. The current Current Deferred Revenue is JOD0.00 Mil. Ibn Alhaytham Hospital's overall GF Score™ is 33/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Deferred Revenue calculated?
Current Deferred Revenue is calculated from a company's financial statements. For Ibn Alhaytham Hospital (AMM:IBNH), the current Current Deferred Revenue is JOD0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ibn Alhaytham Hospital (AMM:IBNH) Overvalued in 2026?

Based on GuruFocus' analysis, Ibn Alhaytham Hospital stock appears to be overvalued. The current stock price of JOD0.86 is trading 2.4% above its estimated GF Value™ of JOD0.84. GuruFocus considers Ibn Alhaytham Hospital to be Fairly Valued.

Key valuation signals for AMM:IBNH:

  • Current Deferred Revenue: JOD0.00 Mil
  • GF Value™: JOD0.84 vs. price of JOD0.86 (2.4% above fair value)
  • GF Score™: 33/100 with 9 warning signs

No single metric tells the full story. See the AMM:IBNH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ibn Alhaytham Hospital Business Description

Address Al-Madina Al-Monawara Street, Amman, JOR, 11194
Ibn Alhaytham Hospital operates as a hospital in Jordan. The Company's main objectives is to found and establish a hospital for general casses And especially ophthalmology, Otorhinolaryngology, Medicine and Neurosurgery and to Import a necessary medical equipment and supplies. The company operates in segments, which comprise of Medical & investments and others.
33GF Score

Get the complete analysis for AMM:IBNH

Current Deferred Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

JOD0.86
Price
JOD0.84
GF Value